Literature DB >> 11961032

Anemia management in chronic kidney disease: role of factors affecting epoetin responsiveness.

Joseph W Eschbach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11961032     DOI： 10.1097/01.asn.0000016440.52271.f7

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  11 in total

1.  Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients.

Authors:  David A Goodkin; Douglas S Fuller; Bruce M Robinson; Christian Combe; Richard Fluck; David Mendelssohn; Tadao Akizawa; Ronald L Pisoni; Friedrich K Port
Journal:  J Am Soc Nephrol       Date:  2010-12-16       Impact factor: 10.121

Review 2.  The diagnostic plot: a concept for identifying different states of iron deficiency and monitoring the response to epoetin therapy.

Authors:  Christian Thomas; Andreas Kirschbaum; Dieter Boehm; Lothar Thomas
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

Review 3.  Molecular and clinical aspects of iron homeostasis: From anemia to hemochromatosis.

Authors:  Manfred Nairz; Günter Weiss
Journal:  Wien Klin Wochenschr       Date:  2006-08       Impact factor: 1.704

4.  Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes.

Authors:  Lynda A Szczech; Huiman X Barnhart; Jula K Inrig; Donal N Reddan; Shelly Sapp; Robert M Califf; Uptal D Patel; Ajay K Singh
Journal:  Kidney Int       Date:  2008-07-02       Impact factor: 10.612

5.  Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients.

Authors:  Ryan D Kilpatrick; Cathy W Critchlow; Steven Fishbane; Anatole Besarab; Catherine Stehman-Breen; Mahesh Krishnan; Brian D Bradbury
Journal:  Clin J Am Soc Nephrol       Date:  2008-04-16       Impact factor: 8.237

6.  Effect of erythropoietin on hepatic cytochrome P450 expression and function in an adenine-fed rat model of chronic kidney disease.

Authors:  D A Feere; T J Velenosi; B L Urquhart
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

7.  Oxidative stress during erythropoietin hyporesponsiveness anemia at end stage renal disease: Molecular and biochemical studies.

Authors:  Samar K M Khalil; H A Amer; Adel M El Behairy; Mohamad Warda
Journal:  J Adv Res       Date:  2016-02-23       Impact factor: 10.479

Review 8.  Iron deficiency anemia in heart failure.

Authors:  Natasha P Arora; Jalal K Ghali
Journal:  Heart Fail Rev       Date:  2013-07       Impact factor: 4.214

Review 9.  Should we reconsider iron administration based on prevailing ferritin and hepcidin concentrations?

Authors:  Takeshi Nakanishi; Takahiro Kuragano; Shoji Kaibe; Yasuyuki Nagasawa; Yukiko Hasuike
Journal:  Clin Exp Nephrol       Date:  2012-09-29       Impact factor: 2.801

10.  The antioxidant effect of erythropoietin on thalassemic blood cells.

Authors:  Johnny Amer; Mutaz Dana; Eitan Fibach
Journal:  Anemia       Date:  2010-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.